Thermo Fisher Scientific has launched the new Gibco CTS DynaCellect Magnetic Separation System (DynaCellect) to improve the cell therapy manufacturing process.
The closed and automated DynaCellect instrument enables accurate cell isolation, cell activation, cell depletion and Dynabeads magnetic beads removal.
It seeks to enable cell therapy developers to smoothly transition from clinical development to commercial manufacturing by offering a scalable, flexible and end-to-end closed system.
